Sharps Technology Inc. - Common Stock (STSS)

Sharps (NASDAQSTSS), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, has announced the closing of its firm commitment underwritten public offering. The company secured approximately $20.0 million in gross proceeds from the offering that closed on Jan. 29, 2025. The company granted Aegis Capital Corp. a 45-day option to purchase additional shares of common stock and/or warrants as detailed in the announcement. Aegis acted as the sole book-running manager for the offering. Sichenzia Ross Ference Carmel LLP acted as counsel to the company, and Kaufman & Canoles, P.C. acted as counsel to Aegis.

Sharps Technology Inc. (NASDAQSTSS) has closed a secured bridge loan financing of approximately $3.5 million. Investors purchased $4.375 million in aggregate principal amount of secured notes along with 5.7 million shares of common stock. The company plans to use the funds, combined with existing cash, for general corporate purposes and working capital. Aegis Capital Corp. served as the exclusive placement agent for the private placement, which was offered solely to accredited investors.

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQSTSS).

Sharps Technology (NASDAQSTSS), a medical-device company, has filed forms with the U.S. Securities and Commission to enter into subscription agreements with certain institutional investors. The agreement calls for the company to issue and sell to the investors 2,239,000 shares of common stock, par value $0.0001 per share of the company at a price of $0.38 per share. The agreements are anticipated to results in gross proceeds of $850,820 for STSS. According to the announcement, Aegis Capital Corp. is acting as the exclusive placement agent for the offering, which closed on June 13, 2024. “Additionally, pursuant to a warrant inducement agreement entered into on June 13, 2024, between the company and certain investors, the investors exercised 1,000,000 warrants and the company received $330,000 in gross proceeds, before deducing placement agent fees and commission, and issued an aggregate of 1,000,000 new warrants that are exercisable at $0.45 per share,” stated the company in the SEC filing. “The new warrants will expire on the five-year anniversary of their initial exercise date, which is six months from issuance.”

ORLANDO, FL / ACCESSWIRE / June 7, 2024 / RedChip Companies will air interviews with Soligenix, Inc. (Nasdaq:SNGX) and Sharps Technology Inc. (Nasdaq:STSS) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, June 8, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

Sharps Technology (NASDAQSTSS), a medical device company, has announced a Reg A+ warrant inducement offering. The offering, which was announced earlier this week, is estimated to reach approximately $2.2 million. The company has filed the required forms for the offering with the U.S. Security Exchange Commission (“SEC”). According to the announcement, Aegis Capital Corp. is acting as the exclusive placement agent for the offering. Aegis Capital Corp. has been in the wealth-management and investment-banking business for four decades.

After a fresh news release and strategic developments, three penny stocks have seen impressive, abnormal volume and price surges today.

NEW YORK, NY / ACCESSWIRE / September 29, 2023 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $5.6 Million Registered Direct & Private Placement Priced at the Market Under Nasdaq Rules for Sharps Technology, Inc. (NASDAQSTSS).

ORLANDO, FL / ACCESSWIRE / September 29, 2023 / RedChip Companies will air interviews with Sharps Technology, Inc. (NASDAQSTSS), Reviva Pharmaceuticals Holdings, Inc. NASDAQ:RVPHNASDAQRVPH)(NASDAQ:ARECNASDAQAREC on The RedChip Money Report®, a sponsored program on Bloomberg TV, this Saturday, September 30, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

EQNX::TICKER_START (NASDAQSTSS),NYSE:STVNNYSESTVN)(NYSE:WSTNYSEWST,(NYSE:BDXNYSE),(NYSE:PFEPFE) EQNX::TICKER_END

NEW YORK, NY - (NewMediaWire) - September 22, 2023 - Sharps Technology, Inc. (NASDAQSTSS), is pleased to announce its CEO, Robert Hayes, recently conducted an interview with SmallCapsDaily providing insights into the Company's innovative drug delivery technologies. Hayes discussed Sharps' vision for the pharmaceutical and healthcare industry, emphasizing the groundbreaking smart safety syringe technology and specialty copolymer-based prefillable syringe systems. Additionally, he highlighted the strategic partnership with Nephron Pharmaceuticals, outlining how it positions Sharps for transformative growth in the drug delivery market.

NEW YORK, NY - (NewMediaWire) - September 22, 2023 - Sharps Technology, Inc. (NASDAQSTSS), is pleased to announce its CEO, Robert Hayes, recently conducted an interview with SmallCapsDaily providing insights into the Company's innovative drug delivery technologies. Hayes discussed Sharps' vision for the pharmaceutical and healthcare industry, emphasizing the groundbreaking smart safety syringe technology and specialty copolymer-based prefillable syringe systems. Additionally, he highlighted the strategic partnership with Nephron Pharmaceuticals, outlining how it positions Sharps for transformative growth in the drug delivery market.

New podcast series shines a spotlight on undervalued small-cap and microcap stocks

ORLANDO, FL / ACCESSWIRE / May 19, 2023 / RedChip Companies will air new interviews with Sharps Technology, Inc. (NASDAQ:STSS; STSSW) and BullFrog AI Holdings, Inc. (NASDAQ:BFRG; BFRGW) on The RedChip Money Report® on Bloomberg TV, this Saturday, May 20, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

ORLANDO, FL / ACCESSWIRE / April 5, 2023 / RedChip Companies will air new interviews with BullFrog AI (NASDAQBFRG) and Sharps Technology NASDAQ:STSSNASDAQSTSS)

By David Willey, Benzinga

By David Willey, Benzinga

NEW YORK, NY / ACCESSWIRE / February 6, 2023 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.8 Million Private Placement for Sharps Technology, Inc. (NASDAQSTSS).

By David Willey, Benzinga

The drug delivery system is a device that enables the introduction of a drug in the body and improves its efficacy and safety by controlling the rate, time, and place of release of drugs in the body. The systems include drug delivery devices without drugs, such as auto-injectors, jet-injectors, and syringes. The manufacturers of drug delivery systems either distribute their products to pharmaceutical companies or consumers through various pharmacies such as retail pharmacies, hospital pharmacies, and online pharmacies. The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. A report from Fortune Business Insights projected that the global drug delivery systems market size, which was valued at USD 34.70 billion in 2021, is projected to grow from USD 39.33 billion in 2022 to USD 71.75 billion by 2029, exhibiting a CAGR of 9.0% during the forecast period. The report said: "The growing vaccination drives to minimize the spread of COVID-19 are expected to fuel the demand for these systems during the forecast period. Moreover, factors such as the surging number of chronic diseases, growing awareness and adoption of advanced drug delivery systems, and the emerging novel technologies drive the market. Furthermore, the market players focusing on various strategies such as new product launches and collaborations are expected to contribute to the market growth in the coming years. The impact of COVID-19 is expected to result in considerable growth of the market during the analysis period. This is attributed to the significant acceleration in the production of injectable drug delivery systems by manufacturers coupled with the increase in COVID-19 vaccination across the world. The market witnessed an increase of 26.2% in 2021 as compared to 2020." Active Companies in the markets today include

By David Willey, Benzinga

EQNX::TICKER_START (NASDAQSTSS),NYSE:BDXNYSEBDX)(NYSE:CAHNYSECAH,(NYSE:NVONYSE),(OTCPK:TRUMY),(NASDAQ:STSSWSTSSW) EQNX::TICKER_END

NEW YORK, NY / ACCESSWIRE / April 19, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a ~$16 Million Initial Public Offering for Sharps Technology, Inc. (NASDAQSTSS). About Sharps Technology, Inc. Sharps Technology, Inc. is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through compassionate innovation. Sharps Provensa™ is the Company's premier line